A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Clinical trial NCT02519439 · TERMINATED

Trial details

NCT number: NCT02519439
Sponsor: Marinus Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Drug Resistant Partial Onset Seizure

Start date: 2015-02-01
Primary completion: 2016-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.